FDA abruptly cancels flu shot meeting. There are no plans to reschedule so far.
On Wednesday afternoon, members of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) learned that its upcoming meeting to determine which strains of influenza should be used in the 2025-2026 seasonal flu shot had been canceled.
One member of the committee, Dr. Paul Offit, confirmed the news and spoke to Inside Medicine. Here is a readout of our phone conversation, edited for clarity and flow: